Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors
- Author
- Kiran Toti (UGent) , Frederick Verbeke (UGent) , Martijn Risseeuw (UGent) , Vladimir Frecer, Hélène Munier-Lehmann and Serge Van Calenbergh (UGent)
- Organization
- Keywords
- Phosphate bioisosteres, 5-Hydroxymethyl pyrimidines, MONOPHOSPHATE KINASE, DRUG DISCOVERY, IN-VITRO, ANALOGS, DNA, REDUCTION, DESIGN, Nucleoside analogues, Inhibitor, Thymidine monophosphate kinase, Mycobacterium tuberculosis
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 907.20 KB
-
Synthesis and Evaluation of 5 -Modified Thymidines and 5-Hydroxymethyl-2 -Deoxyuridines as M. tuberculosis Thymidylate Kinase Inhibitors.pdf
- full text
- |
- open access
- |
- |
- 551.15 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-3192256
- MLA
- Toti, Kiran, et al. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, no. 1, 2013, pp. 257–68, doi:10.1016/j.bmc.2012.10.018.
- APA
- Toti, K., Verbeke, F., Risseeuw, M., Frecer, V., Munier-Lehmann, H., & Van Calenbergh, S. (2013). Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY, 21(1), 257–268. https://doi.org/10.1016/j.bmc.2012.10.018
- Chicago author-date
- Toti, Kiran, Frederick Verbeke, Martijn Risseeuw, Vladimir Frecer, Hélène Munier-Lehmann, and Serge Van Calenbergh. 2013. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY 21 (1): 257–68. https://doi.org/10.1016/j.bmc.2012.10.018.
- Chicago author-date (all authors)
- Toti, Kiran, Frederick Verbeke, Martijn Risseeuw, Vladimir Frecer, Hélène Munier-Lehmann, and Serge Van Calenbergh. 2013. “Synthesis and Evaluation of 5’-Modified Thymidines and 5-Hydroxymethyl-2’-Deoxyuridines as Mycobacterium Tuberculosis Thymidylate Kinase Inhibitors.” BIOORGANIC & MEDICINAL CHEMISTRY 21 (1): 257–268. doi:10.1016/j.bmc.2012.10.018.
- Vancouver
- 1.Toti K, Verbeke F, Risseeuw M, Frecer V, Munier-Lehmann H, Van Calenbergh S. Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors. BIOORGANIC & MEDICINAL CHEMISTRY. 2013;21(1):257–68.
- IEEE
- [1]K. Toti, F. Verbeke, M. Risseeuw, V. Frecer, H. Munier-Lehmann, and S. Van Calenbergh, “Synthesis and evaluation of 5’-modified thymidines and 5-hydroxymethyl-2’-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors,” BIOORGANIC & MEDICINAL CHEMISTRY, vol. 21, no. 1, pp. 257–268, 2013.
@article{3192256, author = {{Toti, Kiran and Verbeke, Frederick and Risseeuw, Martijn and Frecer, Vladimir and Munier-Lehmann, Hélène and Van Calenbergh, Serge}}, issn = {{0968-0896}}, journal = {{BIOORGANIC & MEDICINAL CHEMISTRY}}, keywords = {{Phosphate bioisosteres,5-Hydroxymethyl pyrimidines,MONOPHOSPHATE KINASE,DRUG DISCOVERY,IN-VITRO,ANALOGS,DNA,REDUCTION,DESIGN,Nucleoside analogues,Inhibitor,Thymidine monophosphate kinase,Mycobacterium tuberculosis}}, language = {{eng}}, number = {{1}}, pages = {{257--268}}, title = {{Synthesis and evaluation of 5'-modified thymidines and 5-hydroxymethyl-2'-deoxyuridines as Mycobacterium tuberculosis thymidylate kinase inhibitors}}, url = {{http://doi.org/10.1016/j.bmc.2012.10.018}}, volume = {{21}}, year = {{2013}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: